Lambda, a COVID-19 'variant of interest,' reported in Houston
Houston Methodist Hospital has confirmed its first case of the Lambda coronavirus variant, the Texas hospital system announced Tuesday.
First detected in Peru in December, Lambda has been designated as "a variant of interest" by the World Health Organization, and shares mutations in common with the Gamma variant, which is dominant in Brazil. While Lambda is the predominant strain in Peru, health officials say the Delta variant is still the primary concern in the U.S.
"There's a lot more evidence that we have that Delta is much more contagious, the viral loads are much higher," Dr. Wesley Long, medical director of Diagnostic Microbiology at Houston Methodist, told ABC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are 185 COVID-19 patients in the Houston Methodist Hospital, as of Monday, and 85 percent have been diagnosed with the Delta variant; a majority are unvaccinated. The hospital system said there is an "alarming spike in the number of COVID-19 cases across the Houston area, with the steepest increase happening over the weekend. The increased hospitalizations add stress to many of our hospitals that are nearing capacity."
The Delta variant, first detected in India in December, has been designated by WHO as a "variant of concern" and accounts for about 83 percent of all sequenced COVID-19 cases in the U.S., Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said on Tuesday. In Texas, 51 percent of the population 12 and older is fully vaccinated.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
7 drinks for every winter need possible
The Week Recommends Including a variety of base spirits and a range of temperatures
By Scott Hocker, The Week US Published
-
'We have made it a crime for most refugees to want the American dream'
Instant Opinion Opinion, comment and editorials of the day
By Anya Jaremko-Greenwold, The Week US Published
-
Was the Azerbaijan Airlines plane shot down?
Today's Big Question Multiple sources claim Russian anti-aircraft missile damaged passenger jet, leading to Christmas Day crash that killed at least 38
By Harriet Marsden, The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published